ID   NBsusSR
AC   CVCL_1450
DR   CLO; CLO_0050117
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03472240
DR   cancercelllines; CVCL_1450
DR   Cell_Model_Passport; SIDM00002
DR   ChEMBL-Cells; CHEMBL3308847
DR   ChEMBL-Targets; CHEMBL2366150
DR   Cosmic; 925342
DR   Cosmic-CLP; 925342
DR   DepMap; ACH-002340
DR   GDSC; 925342
DR   GEO; GSM1670156
DR   IARC_TP53; 27185
DR   PharmacoDB; NBsusSR_995_2019
DR   PubChem_Cell_line; CVCL_1450
DR   RCB; RCB0803
DR   Wikidata; Q54907560
RX   PubMed=20164919;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=925342; DepMap=ACH-002340).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Genome ancestry: African=1.34%; Native American=0%; East Asian, North=75.7%; East Asian, South=20.79%; South Asian=0.62%; European, North=0.87%; European, South=0.68% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=925342; RCB=RCB0803
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 34
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).